CanChew Plus

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCanChew Plus
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor agonists
TargetsCannabinoid receptor
Therapy Area/IndicationsPsychotic DisordersIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAxim Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesAxim Biotechnologies Inc
Inactive CompaniesN/A
Active IndicationsPsychotic DisordersIrritable Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A